Abstract:The liver receptor homolog 1 (LRH-1) belongs to the Fushi tarazu factor 1 nuclear receptor subfamily, and its biological functions are just being unveiled. The molecular mechanism for the transcriptional regulation by LRH-1 is not clear yet. In this report, we use mutagenesis and reporter gene assays to carry out a detailed analysis on the hinge region and the proximal ligand binding domain (LBD) of human ( h) LRH-1 that possess important regulatory functions. Our results indicate that helix 1 of the LBD is essential for the activity of hLRH-1 and that the steroid receptor coactivator (SRC)-1 interacts directly with the LBD of hLRH-1 and significantly potentiates the transcriptional activity of hLRH-1. Cotransfection assays demonstrate that overexpressed SRC-1 potentiates hLRH-1 mediated activation of the cholesterol 7-alpha-hydroxylase promoter and increases the transcription of the endogenous cholesterol 7-alpha-hydroxylase in Huh7 cells. The interaction between SRC-1 and hLRH-1 assumes a unique pattern that involves primarily a region containing the glutamine-rich domain of SRC-1, and helix 1 and activation function-2 of hLRH-1 LBD. Mutagenesis and molecular modeling studies indicate that, similar to mouse LRH-1, the coactivator-binding cleft of hLRH-1 LBD is not optimized. An interaction between helix 1 of hLRH-1 LBD and a region containing the glutamine-rich domain of SRC-1 can provide an additional stabilizing force and enhances the recruitment of SRC-1. Similar interaction is observed between hLRH-1 and SRC-2/transcriptional intermediary factor 2 or SRC-3/acetyltransferase. Moreover, transcriptional intermediary factor 2 and acetyltransferase also potentiate the transcriptional activity of hLRH-1, suggesting a functional redundancy among SRC family members. These findings collectively demonstrate an important functional role of helix 1 in cofactor recruitment and reveal a novel molecular mechanism of transcriptional regulation and cofactor recruitment mediated by hLRH-1.

Evaluation of the neutrophil–lymphocyte ratio in newly diagnosed nondiabetic hypertensive patients with ascending aortic dilatation

Ligand-Dependent Coactivation of the Human Bile Acid Receptor FXR by the Peroxisome Proliferator-Activated Receptor Γ Coactivator-1α

Structural Basis for Retinoic X Receptor Repression on the Tetramer

Structure basis of bigelovin as a selective RXR agonist with a distinct binding mode.

Distinct Roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in Nuclear Receptor Transactivation.

Molecular Determinants of Magnolol Targeting Both RXRα and PPARγ

Structure-guided design of a highly potent RXR agonist with superior physicochemical properties

[Reducing cures. For whom? Why? How?].

Retinoid-dependent in vitro transcription mediated by the RXR/RAR heterodimer.

RNA-bound PGC-1α controls gene expression in liquid-like nuclear condensates

Structure-Guided Design of a Highly Potent Partial RXR Agonist with Superior Physicochemical Properties

Structure of the intact PPAR-γ–RXR-α nuclear receptor complex on DNA

PPARγ phase separates with RXRα at PPREs to regulate target gene expression

Activation of PPARγ Coactivator-1 Through Transcription Factor Docking

Structural Fusion of Natural and Synthetic Ligand Features Boosts RXR Agonist Potency

Molecular Mechanism for the Potentiation of the Transcriptional Activity of Human Liver Receptor Homolog 1 by Steroid Receptor Coactivator-1

Cerebral hyponatremia.

Oxaprozin Analogues as Selective RXR Agonists with Superior Properties and Pharmacokinetics

Study of actin filament ends in the human red cell membrane.

Ligand efficacy shifts a nuclear receptor conformational ensemble between transcriptionally active and repressive states

A review of the molecular design and biological activities of RXR agonists